Evidence map›Paper›PMID 33671469›Full record

ArticleInternational journal of molecular sciences2021

The Chemokine Receptor CCR3 Is Potentially Involved in the Homing of Prostate Cancer Cells to Bone: Implication of Bone-Marrow Adipocytes.

Adrien Guérard, Victor Laurent, Gaëlle Fromont, David Estève, Julia Gilhodes, Edith Bonnelye, Sophie Le Gonidec, Philippe Valet, Bernard Malavaud, Nicolas Reina and 2 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Androgens, aging, and prostate health.Reviews in endocrine & metabolic disorders · 2022
    Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Adrien GuérardInstitut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS UMR 5089, 205 Route de Narbonne, 31077 Toulouse, France.
Victor LaurentInstitut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS UMR 5089, 205 Route de Narbonne, 31077 Toulouse, France.
Gaëlle FromontService d'Anatomie Pathologique, CHRU de Tours, Inserm UMR 1069, 37000 Tours, France.
David EstèveInstitut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS UMR 5089, 205 Route de Narbonne, 31077 Toulouse, France.
Julia GilhodesDépartement de Biostatistiques, Institut Universitaire du Cancer, CEDEX 9, 31059 Toulouse, France.
Edith BonnelyeLyos, INSERM, UMR1033, 69008 Lyon, France.
Sophie Le GonidecInstitut des Maladies Métaboliques et Cardiovasculaires (I2MC), INSERM U1048, Université de Toulouse, 31432 Toulouse, France.
Philippe ValetInstitut des Maladies Métaboliques et Cardiovasculaires (I2MC), INSERM U1048, Université de Toulouse, 31432 Toulouse, France.
Bernard MalavaudDépartement d'Urologie, Institut Universitaire du Cancer, CEDEX 9, 31059 Toulouse, France.ORCID 0000-0003-2793-9459
Nicolas ReinaService de Traumatologie et de Chirurgie Orthopédique, CHU de Toulouse-Purpan, 31059 Toulouse, France.
Camille AttanéInstitut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS UMR 5089, 205 Route de Narbonne, 31077 Toulouse, France.
Catherine MullerInstitut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS UMR 5089, 205 Route de Narbonne, 31077 Toulouse, France.
Centre National de la Recherche Scientifique · FRInserm · FRCentre Hospitalier Universitaire de Toulouse · FRInstitut universitaire du cancer de Toulouse Oncopole · FRUniversité Claude Bernard Lyon 1 · FR

Funding

Fondation de France 171352IDEX AAP2015-DISPROCANINCA FOR201302 -CNRS 098488Ligue contre le cancer CNRS 146439
6 · The paper itself

Abstract

Bone metastasis remains the most frequent and the deadliest complication of prostate cancer (PCa). Mechanisms leading to the homing of tumor cells to bone remain poorly characterized. Role of chemokines in providing navigational cues to migrating cancer cells bearing specific receptors is well established. Bone is an adipocyte-rich organ since 50 to 70% of the adult bone marrow (BM) volume comprise bone marrow adipocytes (BM-Ads), which are likely to produce chemokines within the bone microenvironment. Using in vitro migration assays, we demonstrated that soluble factors released by

Indexed as

AdipocytesAgingBone and BonesBone MarrowCell Line, TumorChemokine CCL7ChemotaxisCulture Media, ConditionedHumansMaleNeoplasm MetastasisObesityProstatic NeoplasmsReceptors, CCR3Chemokine CCL7Culture Media, ConditionedReceptors, CCR3bone marrow adipocytesbone metastasisCCR3chemokineprostate cancer

Identifiers

PMID33671469
PMCPMC7922974
OpenAlexW3132890685

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.